A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...

This information comes from health experts with the NIH (National Institute of Mental Health). These reactions usually ...